Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center">AUC</td><td class="align_center">Se</td><td class="align_center">95%CI</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Contrast-enhanced ultrasound</td><td class="align_center">0.608</td><td class="align_center">0.049</td><td class="align_center">0.518∼0.813</td></tr><tr><td class="align_left">MRI</td><td class="align_center">0.667</td><td class="align_center">0.042</td><td class="align_center">0.507∼0.798</td></tr><tr><td class="align_left">Contrast-enhanced ultrasound plus MRI</td><td class="align_center">0.785</td><td class="align_center">0.037</td><td class="align_center">0.642∼0.875</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of ROC results of CEUS, MRI, and the combined application for prostatic cancer.</div>

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: Study on the Diagnostic Value of Contrast-Enhanced Ultrasound and Magnetic Resonance Imaging in Prostate Cancer 